<DOC>
	<DOC>NCT02204410</DOC>
	<brief_summary>This study is a 12-week open-label trial to assess the effectiveness of Omega-3 fatty acids for deficient emotional self-regulation (DESR) as a supplement to ADHD treatment in children and adolescents with Attention Deficit/Hyperactivity Disorder. Subjects will be between the ages of 6-17 and will currently be on medication for their Attention Deficit/Hyperactivity Disorder but still experience DESR traits.</brief_summary>
	<brief_title>Omega-3 Supplementation to ADHD Medication in Children</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Male or female children ages 617 years Living at home A diagnosis of ADHD (inattentive, hyperactive/impulsive, or combined type) according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSMV) based on clinical assessment Having a score outside the normal (a Tscore of 60 or greater) on the Emotional Control subscale of the Behavior Rating Inventory of Executive Function (parentreport version) or a score outside the normal range (cumulative of 180 or greater) on the Anxious/Depressed, Attention Problems, and Aggressive Behavior subscales of the Child Behavior Checklist for ages (618) Currently on FDA approved traditional stimulant medication (such as Concerta of Adderall XR) or nonstimulant medication (such as Strattera or Tenex) for their ADHD for at least one month Beings able to come to weekly/monthly study visits for 12 weeks Having a parent or guardian with a level of understanding of the study Having unstable medical illness as determined by the clinician investigator Having a current diagnosis of schizophrenia or bipolar disorder Having delusions or hallucinations Having a bleeding disorder Taking any other ongoing nonADHD psychotropic medications other than stable, effective serotonin reuptake inhibitors such as fluoxetine (Prozac), citalopram (Celexa) or medications used on an asneeded basis Pregnant or nursing females IQ &lt; 70 by previous testing or as judged by the clinician investigator Illegal substance use Investigator and his/her immediate family; defined as the investigator's spouse, parent, child, grandparent, or grandchild Presence of suicidal risk, or homicidality Unwilling/unable to comply with study procedures Allergies to fish or shellfish or omega 3 fish oils; multiple adverse drug reactions Poor command of the English language</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>DESR</keyword>
	<keyword>Deficient Emotional Self-Regulation</keyword>
	<keyword>Emotional Dysregulation</keyword>
	<keyword>Omega-3 Fatty Acids</keyword>
	<keyword>Fish Oil</keyword>
</DOC>